from the screw thread of a "Soehendra stent retriever" inserted through the stricture, (3) from the proximal end of a blocked biliary stent, and (4) cellular material spun down from a 20 ml specimen of bile. Examination of slides and rinsings was performed by an expert cytologist who graded them for the adequacy of the sample and for evidence of malignancy. Results-Prolonged follow up disclosed malignancy in 52 of the 54 cases, the other two being chronic pancreatitis. Bile samples provided adequate cytology samples in 44%, the Soehendra stent retriever in 70%, retrieved stents in 84%, and cytology brush sampling in 96%. Overall, 28 malignancies were detected by cytology, including 14 of 28 pancreatic carcinomas and 12 of 16 cholangiocarcinomas. Twenty two of the malignancies were detected by brush sampling and the other methods added a total of another six cases.
Many biliary strictures encountered during endoscopic retrograde cholangiopancreatography (ERCP) of jaundiced patients are malignant. However, histological confirmation of malignancy is often not achieved. Rational decisions about treatment depend on a definite diagnosis and the quality of information provided to the patient regarding prognosis is severely compromised by doubt over diagnosis.'
Non-invasive radiological techniques, including ultrasound, computed tomography (CT), and magnetic resonance imaging, are able to provide useful information about the extent of biliary dilatation and the presence or absence of a mass in the head of the pancreas, and are able to identify metastatic disease. These techniques have the limitation that they are unable to provide a definite histological diagnosis, unless they are used to guide percutaneous biopsy or percutaneous fine needle aspiration. Percutaneous sampling techniques are invasive and carry risks of disseminating early tumour. 23 Several techniques have been described to obtain tissue for cytological or histological diagnosis at the time of ERCP. They include intraductal collection of bile for cytology,4 and various endoluminal collection methods: brush cytology, endoscopic forceps biopsy, scrape biopsy, and cytology from a retrieved stent. 5`8 Several groups have published retrospective reviews of their experience with one or two of these methods,9'-but there are few prospective comparative studies,'2 and in no previous study have all these techniques been directly prospectively compared. ' The aim of this study therefore was to compare these ERCP techniques for tissue sampling in jaundiced patients with potentially malignant biliary strictures. The question of whether one sampling technique was sufficient or whether a combination of samples represented optimal clinical practice was considered. In addition, two methods of presenting the cytology specimens, slides made at endoscopy or cytology washings, were compared."3
Methods

PATIENTS
Over a 15 month period (March 1994 to June 1995) all patients with biliary strictures suspicious of malignancy undergoing ERCP at this unit were entered into the study. This resulted in 54 ERCP procedures providing samples for analysis, on a total of 43 patients. Four patients underwent two procedures each, two patients three procedures, and one patient four. All the repeat procedures were performed to replace obstructed biliary stents.
Gastroenterology Unit,
The 54 ERCPs were performed on 24 men and 30 women, median age 69, range 37 to 92. The median duration of their current illness was three months, with a range of two weeks to two and a half years. Their mean bilirubin concentration was 189 (range 5-610, normal <20) mmol, the mean alkaline phosphatase concentration was 599 (range 82-2027, normal 40-120) IU/1, and alanine aminotransferase was 142 (range 17-646, normal <45) IU/1.
ERCP AND SAMPLE CO1ECTION
The ERCPs were carried out using side viewing duodenoscopes (Olympus TJF 10 or JF1T200). Patients received intravenous broad spectrum antibiotics before the procedure and supplemental nasal oxygen before and during the period of intravenous sedation. Pulse oximetry and blood pressure monitoring were performed on all patients. Sedation was with intravenous pethidine, or benzodiazepine (midazolam or diazemuls), or both. Informed consent was obtained.
After visualisation of the biliary stricture a flexible tipped guide wire (Zebra wire, Microvasive, Boston Scientific) was negotiated through. Brush cytology samples were then taken by passing a wire guided sheathed cytology brush (Combocath, Microvasive, Boston Scientific). This single use brush has a double lumen construction, one lumen for the guide wire -which remains in place across the stricture throughout -and the other contains the sheathed brush which is advanced up the stricture only when the sheath is at the lower end of the stricture (Fig 1) . The brush was advanced up and down the stricture five times before being resheathed and the sheathed brush was then withdrawn from the endoscope (Fig 2) .
The cytology specimen was immediately transferred to glass slides by smearing the cellular material from the brush directly on to two slides. The slides were coded and immersed in fixative. The brush was then washed vigorously in fixative to dislodge any further sample. These washings were then coded and despatched to the cytologist.
With the guide wire remaining across the stricture after withdrawal of the brush an 11.5 F Soehendra stent retriever (Wilson Cooke) was advanced over the wire until it abutted the lower end of the stricture. The tip of the stent retriever has a "self tapping" external thread designed to thread the interior of plastic stents before stent removal (Fig 1) . When positioned below the stricture clockwise rotation of the torque transmitting Soehendra instrument pulled the tip into and across the stricture as previously described.8 Progress of the stent retriever through the stricture was checked using fluoroscopic screening. When On removal the tissue -including sludge and sometimes blood clot around the proximal flap of the retrieved stent -was first smeared on to two glass slides and then washed in cytology fixative.
In patients in whom a sphincterotomy was required to allow passage of the stent, biopsies of the stricture were also performed with biopsy forceps passed up the bile duct through the sphincterotomy. Sphincterotomies were not performed routinely because they are known to increase significantly the risk of serious bleeding complications and unnecessarily prolong the procedure."4 At the outset of the study it was anticipated that sphincterotomies would be needed more often. In fact, biopsy specimens were taken on only four occasions by this method.
PROCESSING OF SAMPLES
All samples were coded at the time of ERCP and sent to an expert specialist cytologist (VW), who was blinded to the clinical details and methods of sampling. Samples were scored for adequacy (O=unsatisfactory, 1=scanty, 2= adequate) and for malignancy (1=unsatis-factory, 2=no malignant cells seen, 3=atypical cells ?reactive, 4=suspicious of malignancy, and 5=clearly malignant) (Fig 3) . Carcinoma of the pancreas was the final diagnosis in 28 cases, cholangiocarcinoma in 16, ampullary carcinoma in three, metasatic malignancy in five (two carcinomas of the bowel, one adenocarcinoma with widespread metasases but unknown primary, one carcinoma of breast, and one malignant melanoma). Two cases were chronic pancreatitis.
The survival after ERCP was dependent on the diagnosis and frailty of the patient. Of the 37 patients who died during follow up the mean survival was five months, range one week to 18 months. Twenty one of 28 cases of carcinoma of the pancreas (75%) died after a mean of 5-8 months (range one week to 18 months), 1 1 of 16 cases of cholangiocarcinoma (69%) died a mean of 3-6 months after ERCP; the other patients with these diagnoses were alive at the end of follow up. The patients with chronic pancreatitis were both alive at the end of follow up (15 and 19 months Metastatic carcinoma (n=5) with a final diagnosis of malignancy (false negatives). When the different final diagnoses were analysed separately the sensitivity for cholangiocarcinoma was 75%, pancreatic carcinoma 50%, and metastatic carcinoma 40%. These calculations are based on cytology reports of clearly malignant and suspicious of malignancy being indicative of malignancy. If only reports of clearly malignant were included the sensitivity was lower: cholangiocarcinoma 44%, pancreatic carcinoma 18%. All the sampling methods were similar in being more effective at identifying tumours arising from the bile duct than from pancreas ( Table II) .
Biopsy of the bile duct stricture was only performed in four cases. Two of these were ampullary tumours and one was a cholangiocarcinoma and one a pancreatic neoplasm. The biopsy specimens provided histologically malignant tissue in one of the ampullary tumours and in the cholangiocarcimoma, but no malignant tissue was seen in the other two cases. In the case ofthe ampullary tumour the positive biopsy specimen was the only sample to yield a malignant diagnosis as the cytology specimens were atypical with ?reactive changes.
Two cases had a final diagnosis of benign chronic pancreatitis. Both patients are still alive and well. The cytology samples from these patients were all benign, but clearly this is too few patients with benign disease to confirm meaningfully the sensitivity of 100%.
In 11 cases the cytology was reported as "atypical cells, ?reactive changes". This referred to definitely abnormal cells but without cytological features of malignancy. In three of these cases malignancy was identified in one or more of the other samples, but in the remaining eight the other samples were benign. All these cases with atypical cells had a final diagnosis of malignancy: pancreatic carcinoma in nine, cholangiocarcinoma in one, and ampullary carcinoma in one. If these atypical cytology reports were to be interpreted as positive the overall sensitivity would rise to 69% and the sensitivity for pancreatic carcinoma to 79%.
In the 11 ERCPs which were performed on patients who had already undergone one ERCP earlier in the study the diagnosis of malignancy on brush cytology was made in five of the 11 cases (45%). This compared with 17 of 41 (41 5%) of the malignancies detected by brushing in the non-repeated cases (NS). Neither previous cytology sampling nor previous biliary stenting made any difference to the likelihood of positive cytology.
When the endoscopist's diagnosis at the end of the ERCP was compared with the final diagnosis there were six occasions when the initial diagnosis proved incorrect, five cases turning out to be malignant when benign disease seemed likely and one case of chronic pancreatitis in which malignancy was diagnosed by the endoscopist. In all these cases the cytological diagnosis proved correct. Discussion This is the first prospective study to compare four different methods of cytology sampling from biliary strictures. It has clearly identified brush cytology as the best technique of the four under study. Exfoliative bile cytology performed poorly compared with cytology brush sampling. It had been hoped that the Soehendra stent retriever might provide an even better sampling method than brushings, as the screw thread of the stent retriever engages in the tissue of the stricture and potentially allows for cells deeper in the bile duct mucosa to be sampled.8 This study has shown that this is not the case, the cytology brush samples were more likely to be of adequate cellularity and more likely to identify malignancy than those from the stent retriever.
Previous reports of the value of brush cytology in biliary strictures have provided a wide range of sensitivity: zero to 91% for pancreatic carcinoma and 20% to 100% for cholangiocarcinoma (Table III) .6 9-12 15-18 This wide variation, mainly based on small studies, highlights the need for relatively large prospective comparative studies such as this to provide an assessment of the real value. Several previous studies have taken the form of retrospective reviews of two or more different methods, this approach has been compromised because patients in whom there was doubt over the final diagnosis were often excluded on the grounds of insufficient follow Up.9 10 16 19 20 Other studies have been reported by the originators of particular methods whose results and technical expertise may not always be reproducible by other teams. 8 used without difficulty once deep cannulation of the common bile duct has been achieved. This study has shown that there is an additional benefit to using multiple sampling methods, increasing the sensitivity from 38% to 50% for carcinoma of the pancreas and from 63% to 75% for cholangiocarcinoma. Whether this is worthwhile will ultimately depend on the value attached to each additional diagnosis confirmed. It would seem prudent to use both brushings and retrieved stents for cytology samples whenever possible. The addition of Soehendra stent retriever and exfoliative biliary cytology to the other methods in our series added only another three malignancies.
We prefer to avoid performing a sphincterotomy in jaundiced patients wherever possible to minimise complications.'4 For this reason only four patients had biopsy specimens taken from their biliary strictures. Of these one provided confirmation of an ampullary tumour but the other three did not add to the information provided by the cytology samples. The recently developed bile duct biopsy forceps may enable biliary strictures to be biopsied more easily. Sensitivities of 640/o-81% have been reported with such biopsy specimens although many patients did require a sphincterotomy before biopsy.22 23 Cytology slides and cytology washings have not been compared before in this setting although both are in common use.24 In this study we have shown that either technique gave satisfactory samples in 740/o-80% of cases and scanty samples in 1°/o-180/%, and using both slides and washings increased this to 86% adequate, 11% scanty, and only 3% unsatisfactory.
The difference in sensitivity between cholangiocarcinoma (75%), and pancreatic carcinoma (50%) reflects the closer proximity of the biliary stricture to the primary pathology when the tumour is of bile duct origin. Other groups have also reported this trend.9 10 13 Endoscopic fine needle aspiration using a specially designed needle may allow improvement in the sampling of pancreatic tumours causing bile duct strictures. One report using this approach enabled 73% of pancreatic carcinomas to be correctly identified '7 
